Sunday, January 8, 2017

EY: Biopharma M&A Will Soar in 2017

EY's M&A Outlook and Firepower Report 2017 found that the biopharma industry will continue pursuing M&A to make up for shortfalls in revenue ...

more here
Posted at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)